{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T05:08:24Z","timestamp":1724821704345},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T00:00:00Z","timestamp":1395100800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0092187","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T21:00:19Z","timestamp":1395176419000},"page":"e92187","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacological Inhibition of TPL2\/MAP3K8 Blocks Human Cytotoxic T Lymphocyte Effector Functions"],"prefix":"10.1371","volume":"9","author":[{"given":"Fatema Z.","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo D.","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Forman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. David","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,3,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.immuni.2007.08.007","article-title":"Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection","volume":"27","author":"SM Kaech","year":"2007","journal-title":"Immunity"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.4049\/jimmunol.169.12.6842","article-title":"The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells","volume":"169","author":"J Valenzuela","year":"2002","journal-title":"J Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.174.8.4465","article-title":"Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation","volume":"174","author":"JM Curtsinger","year":"2005","journal-title":"J Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.4049\/jimmunol.0900592","article-title":"Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory","volume":"183","author":"P Agarwal","year":"2009","journal-title":"J Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.4049\/jimmunol.172.5.2818","article-title":"IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells","volume":"172","author":"J Chang","year":"2004","journal-title":"J Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"F Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1182\/blood-2008-11-188458","article-title":"Reciprocal responsiveness to interleukin-12 and interferon-alpha specifies human CD8+ effector versus central memory T-cell fates","volume":"113","author":"HJ Ramos","year":"2009","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood-2011-05-357111","article-title":"IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo","volume":"118","author":"FZ Chowdhury","year":"2011","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-065X.2012.01104.x","article-title":"IkappaB kinase regulation of the TPL-2\/ERK MAPK pathway","volume":"246","author":"T Gantke","year":"2012","journal-title":"Immunol Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1128\/MCB.11.8.4088","article-title":"Structure and transforming potential of the human cot oncogene encoding a putative protein kinase","volume":"11","author":"J Miyoshi","year":"1991","journal-title":"Mol Cell Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1073\/pnas.90.6.2251","article-title":"Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation","volume":"90","author":"C Patriotis","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/cr.2010.173","article-title":"Regulation and function of TPL-2, an IkappaB kinase-regulated MAP kinase kinase kinase","volume":"21","author":"T Gantke","year":"2011","journal-title":"Cell Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0092-8674(00)00210-5","article-title":"TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2\/ERK-dependent pathway","volume":"103","author":"CD Dumitru","year":"2000","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1093\/emboj\/cdg386","article-title":"Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40","volume":"22","author":"AG Eliopoulos","year":"2003","journal-title":"EMBO J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1084\/jem.20081461","article-title":"Tpl2 kinase regulates T cell interferon-gamma production and host resistance to Toxoplasma gondii","volume":"205","author":"WT Watford","year":"2008","journal-title":"J Exp Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.immuni.2005.08.013","article-title":"The role of erk1 and erk2 in multiple stages of T cell development","volume":"23","author":"AM Fischer","year":"2005","journal-title":"Immunity"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.4049\/jimmunol.177.9.6098","article-title":"CD28 ligation costimulates cell death but not maturation of double-positive thymocytes due to defective ERK MAPK signaling","volume":"177","author":"DB Graham","year":"2006","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.4049\/jimmunol.181.11.7617","article-title":"The Erk2 MAPK regulates CD8 T cell proliferation and survival","volume":"181","author":"WN D'Souza","year":"2008","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.0903586","article-title":"Glutamine uptake and metabolism are coordinately regulated by ERK\/MAPK during T lymphocyte activation","volume":"185","author":"EL Carr","year":"2010","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/emboj.2011.435","article-title":"The NF-kappaB1 transcription factor prevents the intrathymic development of CD8 T cells with memory properties","volume":"31","author":"R Gugasyan","year":"2012","journal-title":"EMBO J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"52117","DOI":"10.1074\/jbc.M403716200","article-title":"Phosphorylation of threonine 290 in the activation loop of Tpl2\/Cot is necessary but not sufficient for kinase activity","volume":"279","author":"BS Luciano","year":"2004","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.bmcl.2009.05.009","article-title":"Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-alpha production in human whole blood","volume":"19","author":"J Wu","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1248\/bpb.33.1233","article-title":"Inhibition of tumor progression locus 2 protein kinase decreases lipopolysaccharide-induced tumor necrosis factor alpha production due to the inhibition of the tip-associated protein induction in RAW264.7 cells","volume":"33","author":"K Hirata","year":"2010","journal-title":"Biol Pharm Bull"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1248\/bpb.33.133","article-title":"Inhibition of tumor progression locus 2 protein kinase suppresses receptor activator of nuclear factor-kappaB ligand-induced osteoclastogenesis through down-regulation of the c-Fos and nuclear factor of activated T cells c1 genes","volume":"33","author":"K Hirata","year":"2010","journal-title":"Biol Pharm Bull"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/mi.2011.57","article-title":"Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease?","volume":"5","author":"M Lawrenz","year":"2012","journal-title":"Mucosal Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/84264","article-title":"IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production","volume":"2","author":"J Yang","year":"2001","journal-title":"Nat Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.it.2005.11.007","article-title":"MAP kinase kinase kinases and innate immunity","volume":"27","author":"A Symons","year":"2006","journal-title":"Trends Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1073\/pnas.0708381104","article-title":"Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells","volume":"105","author":"C Tsatsanis","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"R886","DOI":"10.1016\/j.cub.2003.10.053","article-title":"MAP kinase modules: many roads home","volume":"13","author":"M Raman","year":"2003","journal-title":"Curr Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrrheum.2009.181","article-title":"Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis","volume":"5","author":"PC Taylor","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.rdc.2010.02.005","article-title":"A multitude of kinases\u2014which are the best targets in treating rheumatoid arthritis?","volume":"36","author":"TM Lindstrom","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"33295","DOI":"10.1074\/jbc.M703694200","article-title":"Pharmacologic inhibition of tpl2 blocks inflammatory responses in primary human monocytes, synoviocytes, and blood","volume":"282","author":"JP Hall","year":"2007","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1016\/j.bmcl.2006.08.102","article-title":"Inhibition of Tpl2 kinase and TNFalpha production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis","volume":"16","author":"Y Hu","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ceb.2009.01.015","article-title":"Targeting protein kinases for the development of anti-inflammatory drugs","volume":"21","author":"P Cohen","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nrd2829","article-title":"Targeting innate immunity protein kinase signalling in inflammation","volume":"8","author":"M Gaestel","year":"2009","journal-title":"Nat Rev Drug Discov"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0092187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:52:01Z","timestamp":1540219921000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0092187"}},"subtitle":[],"editor":[{"given":"Jon CD.","family":"Houtman","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,18]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0092187","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,18]]}}}